Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Viscosupplementation Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The viscosupplementation market has observed significant expansion in recent years. Its value is anticipated to increase from $4.5 billion in 2025 to $4.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.4%. Historically, this market expansion has been fueled by a higher incidence of osteoarthritis, a growing elderly population, innovations in joint care treatments, increased knowledge of viscosupplementation, and an improving orthopedic healthcare infrastructure.
The viscosupplementation market is projected to experience substantial expansion in the coming years. This market is forecast to reach a valuation of $7.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing embrace of regenerative medicine, the integration of digital health monitoring systems, advancements in new hyaluronic acid formulations, the proliferation of ambulatory surgical centers, and increased financial commitments in outpatient orthopedic procedures. Key developments expected throughout the forecast period include the rise of minimally invasive joint treatments, the growing incorporation of regenerative medicine, tailored approaches to osteoarthritis treatment, breakthroughs in injectable hyaluronic acid products, and the ongoing shift towards outpatient orthopedic interventions.
Get A Free Sample Report With In-Depth Market Insights:
Viscosupplementation Market Demand Drivers: What’s Powering Industry Growth?
An increase in the occurrence of osteoarthritis is anticipated to drive the expansion of the viscosupplementation market in the future. Osteoarthritis is defined as a degenerative joint condition, frequently called a prevalent type of arthritis, where joints, primarily in the hips, knees, and hands, begin to deteriorate. Viscosupplementation therapy aids in alleviating pain and promoting fluid bone motion through the direct injection of hyaluronic acid into the bone joints, thereby diminishing discomfort and enhancing bone functionality. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a US-based nonprofit global health research center, indicated that by 2050, there would be a 75% rise in osteoarthritis of the knee and a 50% increase in osteoarthritis of the hand. Consequently, the growing incidence of osteoarthritis is fueling the growth of the viscosupplementation market moving ahead.
Viscosupplementation Market Segment Analysis And Revenue Potential
The viscosupplementation market covered in this report is segmented –
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
Viscosupplementation Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies in the viscosupplementation market are focused on developing innovative products, such as resorbable hyaluronic acid scaffolds, to improve joint lubrication, encourage tissue regeneration, and offer prolonged relief from osteoarthritis symptoms. This aims to enhance patient outcomes and expand available treatment options. A resorbable hyaluronic acid scaffold is a biocompatible, biodegradable structure primarily constructed from hyaluronic acid (HA), a natural polysaccharide found within connective tissues. For example, in May 2023, Anika Therapeutics, Inc., a US-based company specializing in orthopedics, launched Hyalofast. This product is a single-stage, off-the-shelf, resorbable hyaluronic acid scaffold intended for cartilage repair. Hyalofast is designed to offer a hyaluronic acid-based solution for joint preservation, potentially serving as an alternative to more invasive surgical procedures.
Viscosupplementation Market Key Players Shaping Industry Direction
Major companies operating in the viscosupplementation market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.
View The Full Viscosupplementation Market Report:
Viscosupplementation Market Geographic Spread And Regional Opportunities
North America was the largest region in the viscosupplementation market in 2025. The regions covered in the viscosupplementation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
